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Importance: As older adults living in nursing homes are at a high risk of adverse drug-related events,
medications with a poor beneﬁt/risk ratio or with a safer alternative should be avoided.
Objectives: To systematically evaluate the prevalence of potentially inappropriate medication use in
nursing home residents.
Evidence review: We searched in PubMed and EMBASE databases (1990e2015) for studies reporting the
prevalence of potentially inappropriate medication use in people 60 years of age living in nursing
homes. The risk of bias was assessed with an adapted version of the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) checklist.
Findings: A total of 91 articles were assessed for eligibility, and 48 met our inclusion criteria. These
articles reported the ﬁndings from 43 distinct studies, of which 26 presented point prevalence estimates
of potentially inappropriate medication use (227,534 nursing home residents). The overall weighted
point prevalence of potentially inappropriate medication use in nursing homes was 43.2% [95% conﬁ-
dence interval (CI) 37.3%e49.1%], increasing from 30.3% in studies conducted during 1990e1999 to 49.8%
in studies conducted after 2005 (P < .001). Point prevalence estimates reported in European countries
were found to be higher (49.0%, 95% CI 42.5e55.5) than those reported in North America (26.8%, 95% CI
16.5e37.1) or in other countries (29.8%, 95% CI 19.3e40.3). In addition, 18 studies accounting for 326,562
nursing home residents presented 20 distinct period prevalence estimates ranging from 2.3% to 50.3%.
The total number of prescribed medications was consistently reported as the main driving factor for
potentially inappropriate medications use.
Conclusions and relevance: This systematic review shows that almost one-half of nursing home residents
are exposed to potentially inappropriate medications and suggests an increase prevalence over time.
Effective interventions to optimize drug prescribing in nursing home facilities are, therefore, needed.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The number of nursing home residents is rising in most high-
income countries.1 In the United States, the number of nursing home
residents has increased from 1.1 to 1.4 million between 1977 and
2013.2,3 The high prevalence of chronic multimorbidity and symptoms
in this population of frail elderly individuals leads to complex medi-
cation regimens and to excessive polypharmacy.4 A recent systematic014-4699).
g Research Center, Karolinska
and Long-Term Care Medicine. Threview showed that up to 74% of nursing home residentswere exposed
to 10 or more drugs.5 Because of age-related physiological changes,
older adults are at substantially higher risk of adverse drug-related
events (eg, gastrointestinal bleedings, impaired cognitive function,
injurious falls, and evenmortality).6,7 Optimizing drug prescriptions in
nursing homes is, therefore, essential. Medications are considered as
potentially inappropriate for use in older people when the risk of
harmful effects exceeds their expected beneﬁt for the patient or when
a safer, better tolerated or more effective alternative drug is available.8
Since the landmark initiative from Beers et al in 1991,9 several tools
have been developed to help physicians identify these potentially
inappropriate medications.10,11 In the community setting, 2 systematicis is an open access article under the CC BY-NC-ND license (http://creativecommons.
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9862.e2reviews have reported an overall rate of potentially inappropriate
medication use of about 20%.12,13 In contrast, despite serious concern
about the poor outcomes associated with inappropriate drug pre-
scribing in nursing homes,14 no systematic review has been conducted
on the institutionalized elderly. Yet, a comprehensive and comparative
overview of this issue is necessary to inform clinicians, nursing home
directors, and long-term care policy makers.
This systematic review aimed to investigate the prevalence of
potentially inappropriate medication use in nursing home residents
and to explore variations across geographic areas, time periods, and
sets of criteria.
Methods
Design
We conducted a systematic review of the published literature. The
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) checklist is available in Table A1 (Appendix).
Search Strategy
We searched in PubMed and EMBASE databases for relevant arti-
cles published between January 1990 and December 2015, using a
combination of keywords and medical subject heading terms
(Table A2 in Appendix). We limited our search to articles in English,
French, German, or Swedish. The ﬁnal literature search was performed
on December 1, 2015. In addition, the reference lists of included ar-
ticles were screened manually to identify potentially relevant studies.
Eligibility Criteria
Original studies were included if they reported the prevalence of
medications explicitly considered as potentially inappropriate, in
people 60 years of age living in nursing homes, regardless of the
criteria used to assess drug inappropriateness. Studies published
before 1990, investigating exclusively community or hospital settings,
focusing on a single medication or medication group (eg, benzodiaz-
epines), including only older people with speciﬁc physical or intel-
lectual conditions (eg, dementia), or reported in non-peer-reviewed
publications (eg, government working papers) were excluded. Studies
reporting the outcomes of interventions designed to reduce inap-
propriate medication use and studies with a sample size <50 in-
dividuals were also excluded, as they cannot provide representative
prevalence estimates.
Screening and Study Selection
The title and abstract of retrieved articles were ﬁrst screened by 2
investigators (L.M. and K.J.), with predeﬁned eligibility and exclusion
criteria. Duplicates were removed. The full-text copies of potentially
relevant articles were then reviewed for inclusion. Any disagreement
or uncertainty regarding the eligibility of an article was discussed until
a consensus was reached.
Quality Assessment of Studies
The risk of bias in the included studies was assessed by 2 in-
vestigators (L.M. and G.T.) with an adapted version of the Strength-
ening the Reporting of Observational Studies in Epidemiology
(STROBE) checklist15 (Table A3 in Appendix). Articles were given
quality scores ranging from 0 (lowest possible score) to 30 (highest
possible score), and were accordingly classiﬁed as high (25), mod-
erate (20e24), low (15e19), or very low (<15) quality. Discrepancies
between the two reviewers were resolved by consensus.Data Collection
Data were extracted and entered into a standardized spreadsheet
under the following headlines: study characteristics (design, period,
country, geographic coverage, data source, inclusion criteria, sample
size), study population (sex, age, number of prescribed medications),
measurement (point or period prevalence estimates, potentially
inappropriate medication assessment criteria), quantitative results
(total number of potentially inappropriate medications and number of
individuals exposed to at least 1 potentially inappropriatemedication),
and narrative summary of ﬁndings. L.M. extracted all the data, and a
second reviewer (M.L.) independently assessed a random sample of 10
articles to check accuracy. Disagreements and uncertainties regarding
the data were discussed and resolved by consensus.
Data Synthesis
Prevalence estimates of potentially inappropriate medication use
were considered as the main outcome of interest. Thus, results from
studies reporting more than 1 estimation method (eg, comparing
different criteria) were presented for each estimate separately. How-
ever, articles reporting the same estimate for the same study popu-
lation were merged to avoid potential overlap (ie, “double count” of
the same patients by different articles).
Prevalence estimates were calculated as the proportion of nursing
home residents exposed to at least 1 potentially inappropriate medi-
cation at the time of the data collection (point prevalence estimates) or
over the study period (period prevalence estimates). By pooling
together point prevalence estimates and using the sample size as a
weighting factor in random-effects models with unrestricted
maximum likelihood, we modeled an overall average point prevalence
rate with its 95% conﬁdence intervals (CI). To explore potential varia-
tions, this average estimate was then stratiﬁed by geographic area
(“European countries,” “Northern American countries,” and “other
countries”), time period (“Before 2000,” “2000‒2005,” and “2006‒
2014”) and set of criteria. To evaluate the inﬂuence of each study on the
overall prevalence estimate, sensitivity analysis was conducted using
the leave-one-out approach. Considering the heterogeneity in follow-
up time and the lack of information regarding the length of the
exposure to potentially inappropriatemedication use, wewere not able
to compute an average weighted estimate of the period prevalence. All
analyses were carried out using the Agency for Healthcare Research
and Quality-funded, open-source software Open Meta-Analyst (Center
for Evidence-based Medicine, Brown University, Providence, RI).16
Results
Review Process
Searches in PubMed and EMBASE databases yielded 1635 unique
articles, of which 91 were included in the full-text review process. Of
these, 48 articles reporting the results from 43 distinct studies met our
inclusion criteria and were, therefore, included (Figure 1).
Characteristics of Included Studies
The included studies reported a total of 64 estimates of the prev-
alence of potentially inappropriate medication use among a total of
553,814 nursing home residents. As described in Table 1, these studies
were conducted in 18 different countries: 12 were conducted in the
United States (259,802 residents), 6 in Canada (146,377 residents), 20
in Europe (142,298 residents), and 5 in other countries (5337 resi-
dents, including 3343 in Australia). Sixteen studies were conducted
between 1990 and 1999, 9 between 2000 and 2005, and 18 between
2006 and 2014. Most studies (n ¼ 32) assessed the use of potentially
Fig. 1. PRISMA ﬂowchart of the review process. The category “Other” includes 1 study protocol, 3 conference papers, 2 studies about hospitalized individuals, 2 studies focusing on
drug-drug interactions, 1 study including only intermediate-care facilities, and 1 study comparing the prescribing patterns of general practitioners and geriatricians.
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9 862.e3inappropriate medications cross-sectionally and used medication
charts (n ¼ 13), medical records (n ¼ 11), or healthcare databases
(n ¼ 15) to collect data (Table 1). The risk of bias is presented for each
study in Table A4 in Appendix, and visually represented in a funnel
plot of prevalence rate (%) by study population size (Figure A1).
Criteria to Assess Potentially Inappropriate Medication Use
One study used implicit criteria.34 The 42 other studies used 19
different sets of explicit criteria to measure the prevalence of poten-
tially inappropriate medication use in nursing home residents
(Table 1). The different versions of the Beers’ criteria were used in 70%
(n ¼ 30) studies, Screening Tool of Older Person’s Prescriptions
(STOPP) criteria were used in seven studies, Laroche’s list of criteria in
4 studies, the quality indicators established by the Swedish Board of
Health and Welfare in 3 studies, and the Norwegian General Practice
(NORGEP) criteria in 2 studies. Other sets of explicit criteria included
McLeod (2 studies) and START (4 studies). Eleven articles reported the
comparison of 2 distinct sets of explicit criteria.
Point Prevalence of Potentially Inappropriate Medication Use
Twenty-six studies reported a total of 44 distinct point preva-
lence estimates, accounting for 227,534 nursing home residents. Asshown in Figure 2, the overall weighted point prevalence of
potentially inappropriate medication use in nursing homes was
43.2% (95% CI 37.3%e49.1%). Prevalence estimated ranged from
5.4%22 to 95%,33 with sample sizes varying from 5026 to 86,31246
residents. Despite a large heterogeneity in study designs, data
sources and criteria used to identify potentially inappropriate
medications, studies conducted in Europe reported a higher
weighted point-prevalence (49.0%, 95% CI 42.5e55.5) than studies
conducted in North America (26.8%, 95% CI 16.5e37.1), or in other
countries (29.8%, 95% CI 19.3e40.3). Also, compared with studies
conducted between 1990 and 1999, studies conducted after 2005
showed a higher weighted point-prevalence rate of potentially
inappropriate medication use (49.8% vs 30.3%, P < .01). Figure A2 in
the Appendix presents the different estimates categorized by
criteria. We found that both the overall prevalence and the different
area-speciﬁc estimates remained stable in the leave-one-out
sensitivity analysis (Figure A3 in the Appendix).Period Prevalence of Potentially Inappropriate Medication Use
Eighteen studies reported 20 distinct period prevalence estimates
for a total population of 326,562 nursing home residents (Table 2). The
length of the follow-up period varied from 7 to 730 days, although
most studies measured the prevalence of potentially inappropriate
Table 1
Characteristics of Included Studies
Author (Year of Publication) Country Residents Nursing Homes Age Method of Data
Collection
Criteria
No (% Women) No Mean (SD, Range)
Barnett et al17 (2011) Scotland 4557 (72.3%) NR 84.5 (7.5) Record-linkage
healthcare database
Beers 2003
Beers et al18 (1992) and
Beers et al19 (1993)
United States 1106 (80%) 12 84.0 (65 to 107) Medication charts Beers 1991
Bergman et al20 (2007) Sweden 7904 (69.7%) NR 85.0 (NR) Record-linkage
healthcare database
Swedish criteria
Beuscart et al21 (2014) France 9284 (NR) NR NR Administrative data Laroche
Bronskill et al22 (2012) Canada 64,394 (72.5%) 589 84.4 (7.4) Record-linkage
healthcare database
Beers 2003
Chen et al23 (2012) and
Al Aqqad et al24 (2014)
Malaysia 211 (60.7%) 4 77.7 (7.0) Medical records and
interviews
Beers 2003, STOPP
Chiang et al25 (2000) United States 414 (75%) 20 84.0 (NR) Medication charts Beers 1991
Conejos-Miquel et al26 (2010) Spain 50 (76%) 1 84.5 (7.6) Medical records STOPP, START,
Beers 2003
Cool et al27 (2014) France 974 (71.9%) 175 85.8 (8.4) Medication charts Laroche
Dedhiya et al28 (2010) United States 7594 (76.5%) NR 83.1 (6.8) Administrative data Beers 2003
Dhall et al29 (2002) United States 44,562 (68.7%) 1492 41.2%
85 years
SAGE database Beers 1997
Dhalla et al30 (2002) Canada 19,911 (71.8%) NS 82.6 (7.0) Administrative data Beers 1997
Dosa et al31 (2013) United States 176,168 (0.4%) NR NR Record-linkage
healthcare database
HEDIS
Elseviers et al32 (2014) Belgium 1730 (78.1%) 76 84.8 (60 to 104) Medication charts ACOVE, Beers 2003,
BEDNURS
Garcia-Gollarte et al33 (2012) Spain 100 (80%) 6 84.7 (7.5) Medical records STOPP, START,
Australian criteria
Gill et al34 (2001) Canada 355 (NR) 1 79.6 (NR) Medication charts Implicit criteria
Gray et al35 (2003) United States 282 (73.4%) NR 82.9 (7.9) Administrative data
and interviews
Beers 1997
Halvorsen et al36 (2012) Norway 2986 (71.8%) NR 85.3 (7.3) Computerized database NORGEP
Hosia-Randell et al37 (2008) Finland 1987 (80.7%) 20 83.7 (7.7) Medical records Beers 2003
King et al38 (2007) Australia 998 (71%) 15 83.6 (NR) Medication charts Beers 2003
Kölzsch et al39 (2011) Germany 8685 (83.7%) NR 83.6 (7.3) Medication dispensing
database
Laroche
Lane et al40 (2004) Canada 58,719 (73.3%) NR 84.2 (7.5) Administrative data Zhan
Lao et al41 (2013) China 114 (66.7%) 1 86.6 (8.4) Medical records STOPP
Lau et al42 (2004) and
Lau et al43 (2005)
United States 3372 (73.8%) NR 49.6%
85 years
Administrative data Beers 1997
Lunn et al44 (1997) England 101 (77.2%) 5 85.0 (NR) Medication charts Speciﬁcally developed
criteria
Mann et al45 (2013) Austria 1844 (73%) 48 81.0 (12.0) Medication charts Austrian criteria
Morin et al46 (2015) and
Haasum et al47 (2012)
Sweden 86,312 (70.2%) NR 85.6 (7.2) Record-linkage
healthcare database
Laroche, Beers 2012,
NORGEP, PRISCUS,
Swedish criteria
Niwata et al48 (2006) Japan 1669 (74.3%) 17 84.5 (NR) Patients ﬁles Beers 2003
Nygaard et al49 (2003) Norway 1042 (78%) 15 86.3 (6.8) Medication charts BEDNURS, Beers 1997
O’Sullivan et al50 (2013) Ireland 732 (70.2%) 14 83.9 (7.7) Medical records STOPP, Beers 2003
Papaioannou et al51 (2002) Canada 365 (75.6%) NR 84.2 (8.1) Administrative data McLeod
Perri et al52 (2005) United States 1117 (81.6%) 15 84.6 (8.08) Medical records Beers 1997
Piecoro et al53 (2000) United States 20,573 (NR) NR NR Administrative data Beers 1991
Rancourt et al54 (2004) Canada 2633 (74.2%) 29 82.0 (8.0) Medical records Rancourt
Ruggiero et al55 (2010) Italy 1716 (71.7%) NR 83.4 (8.1) InterRAI instrument Beers 2003
Ruths et al56 (2008) Norway 1513 (76%) 23 85.0 (NR) Medication charts Swedish criteria
Ryan et al57 (2013) Ireland 313 (74.4%) 7 84.4 (7.5) Patients ﬁles STOPP, START
Shah et al58 (2012) England and
Wales
10,387 (76.8%) NR 85.5 (NR) Record-linkage
healthcare database
Beers 2003
Sloane et al59 (2002)
Sloane et al60 (2004)
United States 2014 (75.8%) 193 52.0%
85 years
Survey questionnaire Beers 1997
Spore et al61 (1997) United States 2054 (74.1%) 493 82.0 (65 to 109) Medication charts Beers 1991, Stuck
Stafford et al62 (2011) Australia 2345 (75.5%) 41 87* (65 to 106) Medical records Beers 2003, McLeod
Ubeda et al63 (2012) Spain 81 (63%) 1 84.0 (8.0) Medication charts Beers 2003, STOPP
Zuckerman et al64 (2005) United States 546 (74.7%) 59 81.4 (7.3) Medication charts Beers 1997
ACOVE, Assessing Care of Vulnerable Elders; BEDNURS, Bergen District Nursing Home Study; HEDIS, Healthcare Effectiveness Data and Information Set; NORGEP, Norwegian
General Practice; SAGE, Systematic Assessment of Geriatric drug use via Epidemiology (PMID: 10026659); START, Screening Tool to Alert doctors to Right Treatment; STOPP,
Screening Tool of Older Person’s Prescriptions.
*Stafford et al (2011): median age.
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9862.e4medication use over a 1-year (n ¼ 8) or a 3-month (n ¼ 4) period. We
found no association between the follow-up time and the prevalence
of potentially inappropriate medication use: studies investigating
medication use over a 7-day period reported a prevalence ranging
from 16.0%59 to 24.1%,61 while studies using a 1-year follow-up re-
ported prevalence rates ranging from 2.3%40 to 50.3%.42,43Factors Associated With Potentially Inappropriate Medication Use
The total number of prescribed medications was the most
commonly reported factor associated with an increased
likelihood of receiving potentially inappropriate medi-
cations.25,34,35,48e50,52,54,56,57,59,61,63,64 One study also found that
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Fig. 2. Point-prevalence of potentially inappropriate medication use in nursing homes, by geographic area. Black squares represent individual estimates. Size is proportional to the
number of nursing home residents for which the estimate was calculated. The vertical red line indicates the overall weighted average prevalence rate of potentially inappropriate
medications use, while the red diamond and the light-red shade indicate the 95% conﬁdence interval of this overall weighted rate. White diamonds represent the weighted average
prevalence estimates (with their 95% CI) for each geographic area. Horizontal dashed lines represent the range between the lowest and the highest estimates for each geographic
area. Estimates were calculated using random-effect models with unrestricted maximum likelihood weighting. aDiagnosis-dependent criteria only. bDiagnosis-independent criteria
only. cFull set of criteria.
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9 862.e5higher facility-level rates of polypharmacy were correlated with the
prevalence of potentially inappropriate medication use.22 Five studies
reported that age was negatively correlated with potentially inap-
propriate medication use,31,39,45,48,54 5 studies found that higher age
was associated with increased risk of receiving potentially inappro-
priate medications,27,30,32,46,47 and 9 studies found no signiﬁcant
association.34,41e43,50,52,56,57,61 Several studies suggested that cogni-
tive impairment and dementia were associated with a decreased
likelihood of receiving potentially inappropriate medications.29,31,52
One study found that although residents with and without demen-
tia had the same likelihood of receiving potentially inappropriatemedications before nursing home admission, residents with dementia
were 27% less likely to receive potentially inappropriate medications
after nursing home admission.64
Drugs Most Frequently Involved in Potentially Inappropriate
Medication Use
Long-acting benzodiazepines, ﬂuoxetine, tricyclic antidepressant
(eg, amitriptyline), medications with anticholinergic properties (eg,
hydroxyzine and oxybutynin), nonsteroidal anti-inﬂammatory drugs
(eg, propoxyphene), digoxin, proton-pump inhibitors, iron
Table 2
Period-Prevalence Estimates of Potentially Inappropriate Medication Use in Nursing Homes
Study (Year of Publication) Study Design Time Period Studied Sample Size Length of
the Study
Period
Criteria Number of
Residents
with 1 PIM
No Residents No of Days No (%)
Barnett et al17 (2011) Cohort study 2005 to 2006 4557 730 Beers 2003 1690 (37.1%)
Beers et al18 (1992) Cohort study 1990 and 1991 1106 30 Beers 1991 446 (40.3%)
Beuscart et al21 (2014) Cross-sectional study January to March 2012 9284 90 Laroche 3594 (38.7%)
Chen et al23 (2012) Cross-sectional study January to February 2011 211 61 Beers 2003 69 (32.7%)
STOPP 50 (23.7%)
Dedhiya et al28 (2010) Cohort study 2003 7594 365 Beers 2003 3197 (42.1%)
Dhalla et al30 (2002) Cohort study April 1997 to March 1999 19,911 365 Beers 1997 4145 (20.8%)
Dosa et al31 (2013) Cross-sectional study 2004 to 2009 176,168 365 HEDIS 28,970 (16.4%)
Gray et al35 (2003) Cross-sectional study April to December 1998 282 365 Beers 1997 121 (42.9%)
King et al38 (2007) Cross-sectional study February to March 1994 998 7 Beers 2003 185 (18.5%)
Kölzsch et al39 (2011) Cross-sectional study April to June 2007 8685 90 Laroche 1903 (21.9%)
Lane et al40 (2004) Cohort study 2001 58,719 365 Zhan 1328 (2.3%)
Lau et al42,43 (2004) Cross-sectional study 1996 3372 365 Beers 1997 1696 (50.3%)
Lunn et al44 (1997) Cross-sectional study September to November 1993 101 90 Speciﬁcally
developed
criteria
54 (53.5%)
Piecoro et al53 (2000) Cross-sectional study 1996 20,573 365 Beers 1991 6830 (33.2%)
Shah et al58 (2012) Cross-sectional study March 2008 to February 2009 10,387 90 Beers 2003 3428 (33%)
Sloane et al59 (2002)
Slone et al60 (2004)
Cross-sectional study October 1997 to November 1998 2014 7 Beers 1997 322 (16%)
Spore et al61 (1997) Cross-sectional study July to November 1998 2054 7 Beers 1991 495 (24.1%)
Stuck 367 (17.9%)
Zuckerman et al64 (2005) Cohort study 1992 to 1995 546 365 Beers 1997 242 (44.3%)
PIM, potentially inappropriate medication; STOPP, Screening Tool of Older Person’s Prescriptions; HEDIS, Healthcare Effectiveness Data and Information Set.
Spore et al (1997) also used a modiﬁed version of the Stuck criteria (n ¼ 365/2054 patients detected). Dedhiya et al (2010) reported the proportion of nursing home residents
who received PIM between January and December 2003 after having received no PIM from October 2002 through December 2002. Dhalla et al (2002) reported the prevalence
of PIM use both before and after nursing home admission. Considering the aim of this review, we only reported the postadmission estimate.
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9862.e6supplements, ferrous sulfates, and nitrofurantoin were the most
commonly reported inappropriate medications (Table A4 in the
Appendix).
Discussion
This systematic review suggests that almost one-half of nursing
home residents (43%) are exposed to potentially inappropriate
medication use, with increasing prevalence estimates between 1990
and 2014. In a recent systematic review, Opondo et al12 reported an
average prevalence of inappropriate prescriptions of 20% among
community-dwelling elderly (ie, one-half of our estimate in the
nursing home setting).12 Despite the methodological caveats intrinsic
to such comparison, this would suggest that institutionalized older
adults are at greater risk of receiving potentially inappropriate
medications. The association between the place of residence and the
likelihood of being exposed to these medications is, however, subject
to conﬂicting results, with studies reporting signiﬁcantly higher odds
of receiving potentially inappropriate medications for institutional-
ized elderly compared with community-dwellers,46,47,53,58 studies
reporting no signiﬁcant association,17 and studies reporting a
decrease after nursing home admission.40
A higher number of drugs was reported as the main driving factor
for potentially inappropriate medications use. Previous studies and
systematic reviews have indeed emphasized the high prevalence of
polypharmacy in nursing homes, with up to 74% of residents using 10
different medications or more.5 Cognitive impairment was, in
contrast, often found to be associated with a decrease in the use of
potentially inappropriate medications; thus, suggesting a more
cautious prescribing approach for this group of particularly frail older
adults65 (although excessive polypharmacy was found to be common
among nursing home residents with advanced dementia66).
One striking ﬁnding of this review is the wide variation between
geographic areas: the prevalence of potentially inappropriatemedications use seemed to be signiﬁcantly higher in Europe than in
northern American countries. These disparities may be attributable to
4 different factors. First, prior studies suggested that differences in
drug availability costs, reimbursement schemes, and purchasing sys-
tems were mainly responsible for spatial variation in the quality of
drug prescribing.67 Second, the multidose dispensing system imple-
mented in Nordic European countries has been found to substantially
increase the risk of being exposed to potentially inappropriate medi-
cations,68,69 and Scandinavia accounts for a large share of the studies
included in this review. Third, discrepancies in the prevalence of
inappropriate medications use might stem from differences in the
organization of long-term care services across countries,70,71 leading
to signiﬁcant variation in the burden of chronic diseases of nursing
home residents and in the availability of trained geriatricians and
pharmacists, which could in turn affect the patterns of medications
use.72e74 Finally, cultural differences in beliefs, attitudes, and practices
associated with drug prescribing in frail older adults could partially
explain the gap observed in this review between Europe and North
America.75,76 In the United States for instance, the development of
regulation and monitoring instruments,77 the regular update and
dissemination of the Beers criteria by the American Geriatrics Soci-
ety,78,79 and the implementation of the ChoosingWisely campaign in a
large variety of care settings80 have contributed to raising awareness
and concern about the inappropriate use of prescription drugs among
healthcare professionals. In Europe, such ambitious initiatives are still
lacking, in spite of recent efforts.9,81,82
Another important ﬁnding is the increasing prevalence of poten-
tially inappropriate medications use over time. Studies conducted
before 2005 reported lower estimates than studies conducted after-
ward. Part of the explanation most likely lies in the evolution of the
different explicit criteria, which now include a wider range of medi-
cations and may, therefore, artiﬁcially inﬂate the proportion of resi-
dents exposed to potentially inappropriate medications. Nonetheless,
the absence of a decreasing trend since 1990 should raise concern
L. Morin et al. / JAMDA 17 (2016) 862.e1e862.e9 862.e7among healthcare professionals and policymakers: the accumulation
of evidence regarding the adverse outcomes of inappropriate medi-
cations use55,83,84 and the multiplication of validated tools to identify
these medications do not seem to have led to any signiﬁcant
improvement in the quality of prescribing in nursing homes.
In fact, no intervention has yet been proven effective in reducing
the prescription of inappropriate medications in the long-term care
setting, and only a handful of randomized controlled trials have been
reported until now.85 A recent review initiated by the Cochrane
Collaboration concluded that medication reviews have resulted in a
reduction of inappropriate drug use in all 5 studies meeting the
eligibility criteria, but that the level of evidence was, however, too low
to draw any robust conclusion.86 This conclusion is consistent with
studies questioning the effectiveness of policy regulation relying
solely on the implementation of mandatory medication reviews.87
Because of the considerable burden of chronic multimorbidity, dis-
tressing symptoms, and neuropsychiatric disorders among institu-
tionalized elderly, optimizing medication use in nursing homes is
often more complex than in the community setting. The challenge is
not only to avoid speciﬁc drug classes, but also to ﬁnd the proper
balance between the need formanymedications and the potential risk
of adverse event that each additional medication introduces. There-
fore, without adequately designed interventions to improve the
quality of prescribing in nursing homes, the prevalence of inappro-
priate medications use is unlikely to decrease over the course of the
next few years.
The results of this review should be considered in light of several
limitations. First, although we used a carefully designed and system-
atic search strategy, it is possible that studies presenting eligible
prevalence estimates were not reviewed. Second, our overall measure
of the prevalence of potentially inappropriate medication use is
limited in its conclusion by considerable variation between the indi-
vidual estimates. Also, because of the heterogeneity of the studies
included in this review, we could not combine the data in a meta-
regression to identify factors associated with higher or lower risks of
inappropriate medication use. The large diversity of criteria used in
the different studies may also have introduced bias in the overall
prevalence estimate (eg, if studies with the largest sample sizes were
based on the most extensive criteria). However, a recent country-wide
study comparing 5 different sets of criteria found considerable overlap
in the prevalence estimates of potentially inappropriate medications
use.46 Third, using the adapted STROBE guidelines, 11 of the 43
included studieswere categorized as low or very low quality. Although
these studies had small sample sizes (and, therefore, accounted for
only a small fraction of the overall estimate), this may have affected
the robustness of the data. Finally, this review included studies based
on explicit and implicit criteria for potentially inappropriate medica-
tions use in older adults. Yet, although these instruments have been
found to provide reliable and comparable estimates at the population
level, their accuracy and clinical relevance at the patient level has been
debated.46,88,89
Conclusions
This systematic review provides the ﬁrst comprehensive evalua-
tion of potentially inappropriate medications use in nursing homes. It
shows that the use of potentially inappropriate medications affects
almost one-half of all nursing home residents. It also reveals that
European countries report the highest prevalence of potentially
inappropriate medications use and that no signiﬁcant decrease seems
to have occurred over the past 2 decades. Because inappropriate
medications use in frail elderly people leads to severe adverse out-
comes and induces a considerable economic burden on our healthcare
systems, effective interventions to optimize drug prescribing in
nursing home facilities are needed. Future studies should, therefore,be designed to identify the best possible combination of strategies and
instruments to reduce the use of inappropriate medications to a
minimum.
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